Poly(A) Polymerase
Poly(A) Polymerase - M (Molecular Biology) / 1kU / centrifuge tube is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping & Price Notice
Shipping & Price Notice
Details
Details
Product Information
Poly(A) Polymerase uses ATP as a substrate for template-independent addition of adenosine monophosphate to the 3'-hydroxyl termini of RNA molecules.
Source: Recombinant E.coli
Concentration: 5U/μL
Unit Definition: One unit is defined as the amount of enzyme that will incorporate 1nmol of AMP into RNA in a 20μL volume in 10 minutes at 37°C.
Storage Buffer: 20mM Tris-HCl (pH7.5@25℃), 1mM EDTA, 300mM NaCl, 1mM DTT, 0.1%(v/v) Triton X-100,50%(v/v) glycerol.
Companion Product: 10X poly(A) Polymerase Reaction Buffer, Cat#ON-127, 500mM Tris-HCl, (pH7.9@25℃), 2.5M NaCl, 100mM MgCl2.
Key points of operation
Protocol: The standard reaction will produce ~150bp long poly(A)-tail on up to 10μg of capped or uncapped RNA from IVT reactions and co-transcriptional capping reactions need to be purified before adding to the poly(A)-tailing reaction.
- Combine the following reagents:
- Incubate reaction at 37°C for 60 minutes.
- Stop reaction by adding EDTA to final concentration of >11mM.
Security Information
Storage Conditions: -20℃
Quality Assurance: Free of endonuclease, exonuclease and RNase activities.
Physical Purity: >95% by SDS-PAGE.
Reference
1. Bernstein P and Ross J (1989) Poly(A), poly(A) binding protein and the regulation of mRNA stability. Trends Biochem Sci 14: 373–377.
2. Gallie DR (1991) The cap and poly(A) tail function synergistically to regulate mRNA translational efficiency. Genes Dev 5: 2108–2116.
3. Krug, M.S. and Berger, S.L. (1987) Methods Enzymol. 152, 262.
Specifications
Specifications
-
Catalog No.ON-126
-
SourceRecombinant E.coli
-
Purity>95% by SDS-PAGE
-
Storage Condition-20℃
Documentation
Documentation
Product Information
Poly(A) Polymerase uses ATP as a substrate for template-independent addition of adenosine monophosphate to the 3'-hydroxyl termini of RNA molecules.
Source: Recombinant E.coli
Concentration: 5U/μL
Unit Definition: One unit is defined as the amount of enzyme that will incorporate 1nmol of AMP into RNA in a 20μL volume in 10 minutes at 37°C.
Storage Buffer: 20mM Tris-HCl (pH7.5@25℃), 1mM EDTA, 300mM NaCl, 1mM DTT, 0.1%(v/v) Triton X-100,50%(v/v) glycerol.
Companion Product: 10X poly(A) Polymerase Reaction Buffer, Cat#ON-127, 500mM Tris-HCl, (pH7.9@25℃), 2.5M NaCl, 100mM MgCl2.
Key points of operation
Protocol: The standard reaction will produce ~150bp long poly(A)-tail on up to 10μg of capped or uncapped RNA from IVT reactions and co-transcriptional capping reactions need to be purified before adding to the poly(A)-tailing reaction.
- Combine the following reagents:
- Incubate reaction at 37°C for 60 minutes.
- Stop reaction by adding EDTA to final concentration of >11mM.
Security Information
Storage Conditions: -20℃
Quality Assurance: Free of endonuclease, exonuclease and RNase activities.
Physical Purity: >95% by SDS-PAGE.
Reference
1. Bernstein P and Ross J (1989) Poly(A), poly(A) binding protein and the regulation of mRNA stability. Trends Biochem Sci 14: 373–377.
2. Gallie DR (1991) The cap and poly(A) tail function synergistically to regulate mRNA translational efficiency. Genes Dev 5: 2108–2116.
3. Krug, M.S. and Berger, S.L. (1987) Methods Enzymol. 152, 262.
-
Catalog No.ON-126
-
SourceRecombinant E.coli
-
Purity>95% by SDS-PAGE
-
Storage Condition-20℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Enjoy enterprise‑grade quality even with small batch orders.
Integrated Supply & Commercial Scale
With nearly 30 years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical and enzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates a 1.67-million-square-foot oligonucleotide manufacturing facility featuring advanced equipment, including multiple OligoPilot™ and OligoProcess™ synthesizers ranging from 10 to 1,800 mmol. Its 48 flexible production lines enable seamless, one-stop scale-up of API production from gram-level quantities to metric tons, achieving purity of ≥98% while supporting compliance with NMPA, FDA, and EMA regulatory requirements.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
